Here are the DEF 14A proxy statements from Pyxis Oncology, Inc. (PYXS) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PYXS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PYXS filings page.
Pyxis Oncology, Inc. (PYXS) is asking stockholders to approve an increase in authorized common stock from 190,000,000 to 380,000,000 shares. The vote is scheduled for November 13, 2026, and the board recommends voting for the amendment. As of October 8, 2026, 119,583,637 common shares were outstanding; 39,698,811 shares were reserved for outstanding options, restricted stock units and warrants, and 3,072,366 shares were reserved for future equity-plan awards.
Pyxis says it lacks enough authorized, unissued shares to permit exercise of common warrants for up to 49,310,352 shares, issued in connection with an offering that closed October 1, 2026. If stockholders approve the amendment, the company intends to use some of the added authorization to permit warrant exercise. If they do not, the warrants will not be exercisable and may have no value. Future share issuances could dilute earnings per share, book value per share and current stockholders’ voting power. A second proposal would allow adjournment to solicit additional votes if needed.
Pyxis Oncology is asking stockholders to vote at its 2026 virtual annual meeting on June 15, 2026. The proxy seeks approval to elect three Class II directors (Thomas Civik, Freda Lewis‑Hall, M.D., and Michael A. Metzger) and to ratify Ernst & Young LLP as auditor for 2026.
Stockholders of record as of April 20, 2026, holding 62,855,464 outstanding common shares in aggregate, are entitled to vote online, by phone, mail, or during the live webcast after registering at proxydocs.com/PYXS.